University of Pennsylvania

TMA 4

The TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 30 patients have been incorporated: 15 patients have tissue cores from the primary lesion only, 7 patients have tissue cores from normal tissue only, 1 patient has tissue cores from the metastatic lesion only, 6 patients have tissue cores from normal tissue and primary lesions, and 1 patient has tissue cores from both the primary and metastatic lesions.

TMA 3

The TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 9 patients have been incorporated: 4 patients have tissue cores from the primary lesion only, and 5 patients have tissue cores from normal tissue and primary lesions. Of the patients with available clinical annotation, 88.8% are male and 11.1% are female, and racial breakdown is as follows: 88.8% white, and 11.1% black.

TMA 2

The TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 12 patients have been incorporated: 4 patients have tissue cores from the primary lesion only, 2 patient has tissue cores from normal tissue only, 4 patients have tissue cores from the primary lesion and normal tissue, 1 patient has tissue cores from normal tissue, primary and metastatic lesions, and 1 patient has tissue cores from both the primary and metastatic lesions.

TMA 1

The TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 10 patients have been incorporated: 4 patients have tissue cores from the primary lesion only, 5 patients have tissue cores from the primary lesion and normal tissue, and 1 patient has tissue cores from the normal tissue, primary and metastatic lesions. Of the patients with available clinical annotation, 60% are male and 40% are female, and racial breakdown is as follows: 100% white.